MAPT and Alzheimer disease: Mutations or deletions of the TREM2 gene reduce microglia’s ability to clear AD-related β-amyloid and tau proteins, increase the diffusion of neuroinflammatory dystrophies and tau proteins around plaques, and shift microglia from a homeostatic to a pathological state that promotes the onset of AD (4).